Olivier Rascol on amantadine for patients with movement disorders

The Lancet Neurology in conversation with

English - November 17, 2021 23:00 - 28 minutes - 19.6 MB
Life Sciences Science Education stroke alzheimer's epilepsy sleep cerebral multiple sclerosis Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Antonio Uccelli on stems cells for MS

Next Episode: Alberto Costa on memantine in adolescents and young adults with Down syndrome

Olivier Rascol (Toulouse University, France) discusses the uses of amantadine in the treatment of patients with movement disorders, which are the focus of his Personal View in the December issue of The Lancet Neurology.

Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00249-0/fulltext

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv